Answer
Anastrozole (Arimidex) is indicated for hormone receptor-positive advanced breast cancer and adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women, including those who have received 2 to 3 years of adjuvant tamoxifen.
Sources for this answer
- Arimidex 1mg Film-Coated TabletAstraZeneca UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 31Document updated
Sources checked